| Issue |
Title |
File |
| Vol 14, No 1 (2012) |
Opisanie klinicheskikhsluchaev primeneniya kombinatsiys lapatinibom v lecheniiHER2-pozitivnogo rasprostranennogoraka molochnoy zhelezy |
|
|
Bolotina L.V., Kramskaya L.V., Smirnova I.A., Zharikova I.A., Aminov G.G.
|
| Vol 23, No 1 (2021) |
Opportunities for metastatic triple negative breast cancer therapy |
(Rus)
|
|
Ganshina I.P., Gordeeva O.O., Manukyan M.S.
|
| Vol 24, No 4 (2022) |
Opportunities of ICG-fluorescent imaging of lymph nodes during radical cystectomy in patients with bladder cancer: A review |
(Rus)
|
|
Pavlov V.N., Urmantsev M.F., Bakeev M.R.
|
| Vol 21, No 1 (2019) |
Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports |
(Rus)
|
|
Savelyeva M.I., Dudina I.A., Zaharenkova J.S., Ignatova A.K., Ryzhikova K.A., Sozaeva Z.A., Kudlay D.A., Perfileva O.M., Poddubnaya I.V.
|
| Vol 13, No 1 (2011) |
Opredelenie HER2/neu-statusa po gistologicheskomu materialu -est' li prostranstvo dlya diskussii? |
|
|
Borbat A.M., Tkachenko E.V., Pozharisskiy K.M.
|
| Vol 20, No 2 (2018) |
Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved? |
(Rus)
|
|
Zhukova L.G., Ganshina I.P., Khatkova E.I., Tikhomirova T.E., Kondratyeva O.E.
|
| Vol 6, No 2 (2004) |
Optimizatsiya kombinirovannogo lecheniya bol'nykh mestno-rasprostranennym rakom gortanoglotki |
|
|
Madzhidov M.G.
|
| Vol 12, No 4 (2010) |
Optimizatsiya metodov lecheniyakhronicheskogo bolevogo sindroma u bol'nykhs metastazami v kosti disseminirovannogoraka molochnoy zhelezy |
|
|
Kogoniya, L.M., Mos'kin V.G.
|
| Vol 14, No 1 (2012) |
Opukhol' Abrikosova:porazhenie legkikh u rebenka 4 let |
|
|
Seroklinov V.N., Kozhevnikov V.A., Chursin A.A., Bylina E.A., Logvinova T.V., Drachev V.V., Starodubtsev E.G., Mizernitskiy Y.L.
|
| Vol 13, No 1 (2011) |
Opyt dlitel'nogo primeneniya kombinatsii kapetsitabina, lapatiniba i trastuzumabapri HER-2-pozitivnom metastaticheskom rake molochnoy zhelezy. Opisanie klinicheskogo sluchaya |
|
|
Zhukova L.G., Okruzhnova M.A., Lubennikova E.V., Zeynalova K.R.
|
| Vol 12, No 1 (2010) |
Opyt GNTs RAMN po primeneniyunilotiniba (Tasigna) u bol'nykhv khronicheskoy faze khronicheskogomieloleykoza pri neudache terapiiimatinibom |
|
|
Gusarova G.A., Turkina A.G., Domracheva E.V., Tikhonova L.Y., Egorova M.O., Kolosheynova T.I., Stakhina O.V., Nemchenko I.S., Vakhrusheva M.V., Chelysheva E.Y., Zakharova E.S., Goryacheva S.R., Sokolova M.A., Kuznetsov S.V., Afanas'eva N.A., Khoroshko N.D.
|
| Vol 12, No 1 (2010) |
Opyt lecheniya kapetsitabinomi trastuzumabom metastaticheskogoporazheniya golovnogo mozga pri rakemolochnoy zhelezy s giperekspressieyHer-2/neu |
|
|
Naskhletashvili D.R., Chmutin G.E., Karakhan V.B., Aleshin V.A., Fu R.G., Moskvina E.A., Belov D.M., Luk'yanchenko A.B., Ivanova E.A.
|
| Vol 12, No 1 (2010) |
Opyt lecheniya stromal'nykh opukholeyzheludochno-kishechnogo traktav Chelyabinskoy oblasti |
|
|
Antonov A.A., Nadvikova E.A., Vazhenin A.V.
|
| Vol 5, No 1 (2003) |
Opyt primeneniya abitaksela™ v lechenii solidnykh opukholey |
|
|
Blyumenberg A.G., Gutorov S.L., Topchieva S.V., Gorbunova V.A., Lichinitser M.R.
|
| Vol 12, No 3 (2010) |
Opyt primeneniya Avastina (bevatsizumaba)v sochetanii s khimioterapiey v lecheniirasprostranennykh form nemelkokletochnogoraka legkogo v otdelenii torakal'noyonkologii |
|
|
Orlov S.V., Stel'makh L.V., Lozhkina A.M., Poltoratskiy A.N.
|
| Vol 14, No 3 (2012) |
Opyt primeneniya bendamustina u patsientov s retsidivom khronicheskogo limfoleykoza v rezhime monoterapii v ambulatornykh usloviyakh |
|
|
Ivashchenko A.V.
|
| Vol 13, No 1 (2011) |
Opyt primeneniya gefitiniba v lechenii nemelkokletochnogo raka legkikh v Orlovskoy oblasti |
|
|
Golubenko R.A., Gromov G.B., Vishnevskiy V.I.
|
| Vol 14, No 4 (2012) |
Opyt primeneniya kapetsitabina v neoad\"yuvantnoy khimioterapii raka molochnoy zhelezy |
|
|
Slonimskaya E.M., Tarabanovskaya N.A., Bragina O.D., Garbukov E.Y., Doroshenko A.V., Kokorina Y.L., Zav'yalova M.V.
|
| Vol 11, No 1 (2009) |
Opyt primeneniya kapetsitabinau bol'nykh rakom molochnoy zhelezy s metastazami v golovnoy mozg |
|
|
Naskhletashvili D.R., Chmutin G.E., Karakhan V.B., Aleshin V.A., Fu R.G., Belov D.M., Ivanova E.A.
|
| Vol 10, No 2 (2008) |
Opyt primeneniya preparata Eloksatin pri kolorektal'nom rake |
|
|
Voznyy E.K., Popov A.Y., Astrakhankina T.A., Grishunenkova E.P., Polyanskaya E.V.
|
| Vol 9, No 2 (2007) |
Opyt primeneniya preparata Vero-kladribin u bol'nykh volosatokletochnym leykozom |
|
|
Al'-Radi L.S., Moiseeva T.N., Kravchenko S.K.
|
| Vol 7, No 1 (2005) |
Opyt primeneniya Regional'noy programmy v g. Krasnodare |
|
|
Mitashok I.S.
|
| Vol 4, No 3 (2002) |
Opyt primeneniya taksola v khimioterapii ploskokletochnogo raka golovy i shei |
|
|
Podvyaznikov S.O., Byakhov M.Y.
|
| Vol 8, No 1 (2006) |
Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy |
|
|
Samoylenko V.M., Gorbunova V.A., Koshelev M.N., Yurashko K.V.
|
| Vol 15, No 3 (2013) |
Opyt primeneniya Votrienta v kombinirovannom lechenii redkikh mestno-rasprostranennykh sarkom myagkikh tkaney vysokoy stepeni zlokachestvennosti |
|
|
Zubarev A.L., Kuril'chik A.A., Starodubtsev A.L., Ivanov V.E.
|
| Vol 8, No 1 (2006) |
Opyt primeneniya vysokodoznoy khimioterapii pri retsidiviruyushchem techenii i refrakternykh formakh limfomy Khodzhkina (retrospektivnyy analiz dannykh chetyrekh transplantatsionnykh tsentrov Respubliki Belarus', Rossiyskoy Federatsii i Ukrainy) |
|
|
Zhukov N.V., Uss A.L., Afanas'ev B.V., Karamanesht E.E., Ptushkin V.V.
|
| Vol 8, No 2 (2006) |
Opyt profilakticheskogo primeneniya rekombinantnogo faktora Vila dlya umen'sheniya intraoperatsionnykh krovotecheniy u onkologicheskikh bol'nykh |
|
|
Barkagan Z.S., Khodorenko S.A., Mamaev A.N., Nazarov A.V., Mamaeva I.V., Tsyvkina L.P., Rossokha A.V.
|
| Vol 14, No 4 (2012) |
Opyt provedeniya nablyudatel'nykhprogramm v abdominal'noy onkologii |
|
|
- -.
|
| Vol 3, No 2 (2001) |
Opyt trakheobronkhoplasticheskikh operatsiy pri opukholyakh legkikh i trakhei |
|
|
Novikov E.A., Aminodov S.A., Solov'ev V.G., Smirnov A.V.
|
| Vol 14, No 2 (2012) |
Opyt uspeshnogo lecheniya HER2-pozitivnogo metastaticheskogo raka zheludka |
|
|
Gamayunov S.V., Slugarev V.V., Ter-Ovanesov M.D., Zakharova E.M.
|
| Vol 22, No 4 (2020) |
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Alexandrova E.G.
|
| Vol 5, No 3 (2003) |
Oral'nyy vepezid v lechenii retsidivov i platinorezistentnykh form raka yaichnikov (opyt primeneniya) |
|
|
Makhnova E.V.
|
| Vol 5, No 1 (2003) |
Organizatsionno-metodicheskie aspekty realizatsii Regional'noy programmy lecheniya mestno-rasprostranennogo i metastaticheskogo raka molochno y zhelezy s ispol'zovaniem rezhima dotsetaksel/doksorubitsin |
|
|
Podregul'skiy K.E., Poddubnaya I.V.
|
| Vol 3, No 1 (2001) |
Organosokhranyayushchee lechenie - perspektivnoe napravlenie razvitiya onkopediatrii XXI veka |
|
|
Durnov L.A., Sharoev T.A., Polyakov V.G., Ivanova N.M., Lebedev V.I., Pashkov Y.V., Bondar' I.V., Belkina B.M., Boychenko E.I.
|
| Vol 12, No 1 (2010) |
Original'naya kombinatsiyaFtorafur® + vinorelbinv lechenii raka molochnoy zhelezy:pervye rezul'taty |
|
|
Manzyuk L.V., Artamonova E.V., Satirova E.F., Alatortseva E.S.
|
| Vol 8, No 3 (2006) |
Ortopedicheskaya reabilitatsiya onkologicheskikh bol'nykh s defektami verkhney chelyusti |
|
|
Chuykov M., Matyakin E.G., Azizyan R.I., Akhundov A.A., Mudunov A.M., Podvyaznikov O., Fedotov N.N., Chuchkov M.V., Agapov V.V.
|
| Vol 24, No 1 (2022) |
Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report |
(Rus)
|
|
Orlov S.V., Baldin P.L., Diuzeva N.V., Krechetova A.V., Mordovskiy A.A., Moskovchenko A.N., Musaeva N.E., Romanchuk O.V.
|
| Vol 21, No 3 (2019) |
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer |
(Rus)
|
|
Reutova E.V., Laktionov K.P., Iudin D.I., Neliubina L.A., Gorokhova G.K., Egorova A.V.
|
| Vol 7, No 2 (2005) |
Osnovnye aspekty primeneniya bisfosfonatov v onkologii |
|
|
Kondrat'eva A.P.
|
| Vol 5, No 2 (2003) |
Osnovnye napravleniya sovremennoy luchevoy terapii zlokachestvennykh opukholey |
|
|
Kondrat'eva A.P.
|
| Vol 5, No 4 (2003) |
Osnovnye problemy optimizatsii okazaniya onkologicheskoy pomoshchi naseleniyu( Yakutsk, 1992 - 2002 gg.) |
|
|
Poddubnaya I.V., Aksel' E.M., Ivanov P.M., Ivanova R.I., Kipriyanova N.S., Afanas'eva L.N.
|
| Vol 8, No 4 (2006) |
Osobennosti klinicheskogo techeniya i prognoz bol'nykh nekhodzhkinskoy limfomoy s pervichnoy lokalizatsiey v yaichke |
|
|
Tumyan G.S., Kovrigina A.M., Timofeeva O.L., Probatova N.A., Sholokhova E.N., Tupitsyn N.N., Poddubnaya I.V., Osmanov D.S.
|
| Vol 8, No 3 (2006) |
Osobennosti kliniko-morfologicheskikh kharakteristik i lecheniya retsidiva raka yaichnikov IV stadii |
|
|
Mel'ko A.I., Ushakov I.I., Kira E.F., Shamkina V.O., Gaytukieva R.A.
|
| Vol 17, No 3 (2015) |
Osobennosti korrektsii naibolee chastykh nezhelatel'nykh yavleniy na fone primeneniya ingibitorov BRAF i MEK |
|
|
Samoylenko I.V.
|
| Vol 4, No 4 (2002) |
Osobennosti lecheniya bol'noy neorgannoy pleomorfnoy liposarkomoy |
|
|
Blyumenberg A.G., Kuznetsov V.V., Gorbunova V.A., Mikhina Z.P., Borisov V.I., Gubin A.N., Poddubnyy B.K., Petrovichev N.N., Kiselevskiy M.V., Zakharova T.I., Kireev A.V., Vakurova E.S., Rotin D.L.
|
| Vol 9, No 3 (2007) |
Osobennosti profilaktiki posleoperatsionnykh tromboembolicheskikh oslozhneniy u patsientov so zlokachestvennymi zabolevaniyami |
|
|
Pashanov E.D., Zamyatin M.N., Stoyko Y.M., Rumyantsev A.G.
|
| Vol 17, No 3 (2015) |
Osobennosti profilya toksichnosti ingibitorov BRAF i MEK |
|
|
Protsenko S.A.
|
| Vol 10, No 3 (2008) |
Osobennosti reproduktivnoy funktsii u zhenshchin s onkogematologicheskimi zabolevaniyami |
|
|
Shmakov R.G., Polushkina E.S.
|
| Vol 5, No 2 (2003) |
Osobennosti serdechno-dykhatel'nogo sinkhronizma u zhenshchin s razlichnym tonusom vegetativnoy nervnoy sistemy na etape postanovki onkologicheskogo diagnoza |
|
|
Arkad'eva T.V., Selyan N.A.
|
| Vol 13, No 3 (2011) |
Osteopontin, CD55:prognosticheskie faktory riskapri rake molochnoy zhelezy |
|
|
Guzieva Z.M., Poddubnaya I.V., Vishnevskaya Y.V., Makarenko N.P., Sytenkova K.V.
|
| Vol 10, No 3 (2008) |
Ot glavnogo redaktora Uvazhaemye kollegi! |
|
|
Poddubnaya I.V.
|
| Vol 11, No 3 (2009) |
Otdalennye rezul'taty khirurgicheskogo lecheniya gastrointestinal'nykh stromal'nykh opukholey zheludochno-kishechnogo trakta |
|
|
Istomin Y.V., Evdokimov M.Y.
|
| Vol 7, No 3 (2005) |
Otkrytaya mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti kombinirovannoy terapii myustoforanom, tsisplatinom, tamoksifenom patsientov s disseminirovannoy zlokachestvennoy melanomoy |
|
|
Konstantinova M.M., Gershanovich M.L., Akimov M.A., Nosov D.A., Bogdanova N.V.
|
| Vol 3, No 1 (2001) |
Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov) |
|
|
Poddubnaya I.V., Khasanov R.S., Ruchkin V.N., Lazarev A.N., Byakhov M.Y., Vtoraya O.M., Yurchenko V.S.
|
| Vol 14, No 2 (2012) |
Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progressiya opukholevogo protsessa posle khimioterapii taksanami |
|
|
Gafanov R.A., Ivanov S.A., Fastovets S.V., Isaev T.K.
|
| Vol 11, No 3 (2009) |
Otsenka effektivnostii bezopasnosti fotemustinav monorezhime i v kombinatsii s proizvodnymi platiny(karboplatinom ili tsisplatinom) pri lechenii disseminirovannoy melanomy |
|
|
Konstantinova M.M., Savkova R.F., Demidov L.V., Gorbunova V.A., Kharkevich G.Y., Antimonik N.Y., Merkulov V.N., Simanovich E.E., Ral'chenko K.V., Sbrodov O.V.
|
| Vol 3, No 4 (2001) |
Otsenka toksichnosti protivoopukholevogo preparata gemtsitabina (GEM) |
|
|
Mamedov F.F., Narimanov M.N., Bazin I.S., Efimov O.N., Zharkov S.A., Tryakin A.A., Tyulyandin S.A., Garin A.M.
|
| Vol 26, No 1 (2024) |
Outcomes of extracorporeal partial nephrectomy in patients with malignant tumors: a retrospective and prospective study |
(Rus)
|
|
Matveev V.B., Volkova M.I., Sinitsyna O.R., Kuznetsov K.P., Perlin D.V.
|
| Vol 23, No 2 (2021) |
Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer |
(Rus)
|
|
Dalgatov K.D., Semenov N.N., Kozodaeva M.V.
|
| Vol 18, No 1 (2016) |
Outcomes of surgical treatment of advanced gastrointestinal stromal tumors |
(Rus)
|
|
Abouhaidar O.B., Nered S.N., Arkhiri P.P., Nikulin M.P., Stilidi I.S.
|
| Vol 16, No 1 (2014) |
Overcoming immunological tolerance is a way of treating malignant tumors: new perspectives |
|
|
Samoilenko I.V., Kharkevich G.U., Demidov L.V.
|
| Vol 24, No 2 (2022) |
Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report |
(Rus)
|
|
Gushchina E.E., Vernyuk M.A., Chervontseva A.M., Cherkashina I.V., Khayrullina L.S., Lunin V.V., Fedenko A.A.
|
| Vol 19, No 1 (2017) |
Own experience of treatment by epoetin-α (Eralfon®) of chemotherapy induced anemia |
(Rus)
|
|
Bolshakova S.A., Bychkov Y.M., Kazarova M.V.
|
| Vol 24, No 1 (2022) |
Own Experience of Using Lenvatinib in Patients with Advanced Hepatocellular Carcinoma in Real Clinical Practice based on Moscow City Oncological Hospital №62 |
(Rus)
(Eng)
|
|
Volkonsky M.V., Zhikhorev R.S., Makarkina T.A., Filippova V.M., Vasileva Y.V., Akopyan A.A., Zhelezkova T.A.
|
| Vol 24, No 4 (2022) |
Oxycodone for cancer-related pain in adults (Russian Translation of Cochrane Plain Language Summary (PLS)) |
(Rus)
|
|
Bayazitova R.F.
|
| Vol 26, No 4 (2024) |
Pain relief clinical efficacy using pulsed radiofrequency ablation of nerve roots in patients with spine metastatic lesions. A prospective study |
(Rus)
|
|
Kuznetsov S.F., Babkin N.S., Valiev A.K., Kabardaev R.M., Borzov K.A.
|
| Vol 3, No 4 (2001) |
Paklitaksel (taksol): novye vozmozhnosti. Ezhenedel'nyy rezhim vvedeniya |
|
|
Voznyy E.K.
|
| Vol 17, No 3 (2015) |
Pamyati Gianni Bonadonna |
|
|
- -.
|
| Vol 12, No 3 (2010) |
Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti |
|
|
Artamonova E.V.
|
| Vol 4, No 4 (2002) |
Parametry serdechno-dykhatel'nogo sinkhronizma i prognoz razvitiya onkologicheskogo zabolevaniya |
|
|
Arkad'eva T.V., Ostrizhnaya N.G.
|
| Vol 19, No 2 (2017) |
PARP inhibitors in female reproductive system cancers |
(Rus)
|
|
Pokataev I.A., Tyulyandin S.A.
|
| Vol 24, No 1 (2022) |
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer (Russian Translation of Cochrane Plain Language Summary) |
(Rus)
|
|
Uvarova K.G.
|
| Vol 18, No 2 (2016) |
Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary |
(Rus)
|
|
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V.
|
| Vol 15, No 1 (2013) |
Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients |
|
|
Romanenko N.A.
|
| Vol 22, No 3 (2020) |
Patient blood management in oncology in the Russian Federation: resolution to improve oncology care. |
(Rus)
|
|
Hofmann A., Aapro M., Fedorova T.A., Zhiburt Y.B., Snegovoy A.V., Kaganov O.I., Ognerubov N.A., Lyadov V.K., Moiseenko V.M., Trofimova O.P., Ashrafyan L.A., Khasanov R.S., Poddubnaya I.V.
|
| Vol 25, No 4 (2023) |
Patient resource to improve the effectiveness of oncological care for the population |
(Rus)
|
|
Kozlov V.A., Samsonov I.V., Mushnikov D.L.
|
| Vol 14, No 3 (2012) |
Pazopanib v lechenii rasprostranennogo pochechno-kletochnogo raka (klinicheskiy sluchay) |
|
|
Savkov R.V.
|
| Vol 8, No 2 (2006) |
Pemetreksed (alimta) |
|
|
Tyulyandin S.A.
|
| Vol 3, No 2 (2001) |
Perifericheskaya neyrotoksichnost' taksotera |
|
|
Shakirova I.N., Lebedeva L.I., Borisova T.A., Meshcheryakov A.A., Setdikov R.A., Gutorov S.L.
|
| Vol 26, No 3 (2024) |
Perioperative chemotherapy and morphological response in the treatment of gastric cancer: A retrospective study |
(Rus)
|
|
Kiselev N.M., Klimin S.A., Kolesnik Y.I., Kokorin R.S., Ashimov E.А., Elagina V.Y., Shumskaya I.S., Zagainov V.E., Gamayunov S.V.
|
| Vol 20, No 2 (2018) |
Perioperative chemotherapy for gastric cancer: the current state |
(Rus)
|
|
Lyadov V.K., Pardabekova O.A., Lyadova M.A.
|
| Vol 26, No 4 (2024) |
Peritoneal lymphomatosis as the only manifestation of diffuse B-cell large cell lymphoma: A clinical case |
(Rus)
|
|
Ognerubov N.A., Antipova T.S., Poddubnaya I.V.
|
| Vol 16, No 3 (2014) |
Personalized approach to HER2-positive advanced breast cancertherapy |
|
|
Stenina M.B.
|
| Vol 25, No 4 (2023) |
Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review |
(Rus)
|
|
Dinikina Y.V., Zheludkova O.G., Belogurova M.B., Spelnikov D.M., Osipov N.N., Nikitina I.L.
|
| Vol 19, No 2 (2017) |
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy |
(Rus)
|
|
Savelyeva M.I., Ignatova A.K., Panchenko Y.S., Urvantseva I.A., Poddubnaya I.V.
|
| Vol 5, No 2 (2003) |
Perspektiva razvitiya khimioterapii s izucheniem etnicheskogo i individual'nogo polimorfizma sistemy tsitokhromov R-450 v Respublike Sakha (Yakutiya) |
|
|
Ivanova F.G.
|
| Vol 9, No 3 (2007) |
Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei |
|
|
Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
|
| Vol 3, No 3 (2001) |
Perspektivy khimioterapii raka molochnoy zhelezy: vozmozhnosti gemzara po materialam ASCO 2001 g |
|
|
Makarenko N.P.
|
| Vol 14, No 3 (2012) |
Perspektivy primeneniya ademetionina v komplekse intensivnoy terapii bol'nykh s ostroy pechenochnoy nedostatochnost'yu: vzglyad reanimatologa |
|
|
Gromova E.G.
|
| Vol 10, No 3 (2008) |
Pervichnaya mediastinal'nayaV-krupnokletochnaya limfoma: diagnostika, klinicheskaya kartina i lechenie |
|
|
Tumyan G.S., Kovrigina A.M., Kichigina M.Y., Sorokin E.N., Bykov D.A., Kondrat'eva T.T., Probatova N.A., Trofimova O.P., Kolomeytsev O.A., Poddubnaya I.V., Tupitsyn N.N., Larionova V.B., Osmanov D.S.
|
| Vol 5, No 1 (2003) |
Pervichno-mnozhestvennye zlokachestvennye opukholi s porazheniem sosudistoy obolochki glaza |
|
|
Lerner M.Y.
|
| Vol 8, No 4 (2006) |
Pervichnye limfomy kozhi: diagnostika i lechenie |
|
|
Belousova I.E., Krivolapov Y.A.
|
| Vol 3, No 4 (2001) |
Pervichnye MALT-limfomy zheludka u bol'nykh pozhilogo vozrasta |
|
|
Moskalenko O.A., Osmanov D.S., Probatova N.A., Kokosadze N.V., Sholokhova E.N., Kovrigina A.I., Kuvshinov Y.P., Poddubnyy B.K., Poddubnaya I.V.
|
| Vol 13, No 4 (2011) |
Pervichnye nekhodzhkinskielimfomy kostey |
|
|
Sotnikova O.P., Sorokin E.N., Kovrigina A.M., Bykov D.A., Osmanov E.A., Poddubnaya I.V.
|
| Vol 12, No 2 (2010) |
Pervyy opyt luchevogo lecheniyaploskokletochnogo raka orofaringeal'noyzony s radiomodifikatsiey tsetuksimabomi tsisplatinom |
|
|
Boyko A.V., Bolotina L.V., Chernichenko A.V., Gevorkov A.R., Smirnov A.K.
|
| Vol 10, No 3 (2008) |
Pervyy opyt primeneniya alemtuzumaba u bol'nykh khronicheskim limfoleykozom,refrakternykh k fludarabinsoderzhashchim programmam khimioterapii |
|
|
Zagoskina T.P., Malykh O.V., Khorobrykh M.N., Dem'yanova V.I., Isaeva N.V., Grishina I.V.
|
| Vol 23, No 4 (2021) |
Pharmacoeconomic analysis of acalabrutinib in patients with chronic lymphocytic leukemia |
(Rus)
|
|
Nedogoda S.V., Salasyuk A.S., Barykina I.N., Lutova V.O., Popova E.A.
|
| Vol 19, No 1 (2017) |
Pharmacoeconomic aspects of biosimilars |
(Rus)
|
|
Tryakin A.A., Rudakova A.V., Fogt S.N., Vaganov A.S., Tolkacheva D.G.
|
| Vol 19, No 1 (2017) |
Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin |
(Rus)
|
|
Kolbin A.S., Mosikyan A.A., Kurilev A.A., Balykina Y.E., Proskurin M.A.
|
| Vol 15, No 4 (2013) |
Pharmacoeconomic potency assignment of targeted agents in the treatment of metastatic colorectal cancer with wild-type Kras |
|
|
Yagudina R.I., Poddubnaya I.V., Kulikov A.U.
|
| 701 - 800 of 1398 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
